Kinetics of the utilization of dietary arginine for nitric oxide and urea synthesis: insight into the arginine-nitric oxide metabolic system in humans.

BACKGROUND The systemic availability of oral/dietary arginine and its utilization for nitric oxide (NO) synthesis remains unknown and may be related to a competitive hydrolysis of arginine into urea in the splanchnic area and systemic circulation. OBJECTIVES We investigated the kinetics and dose-dependency of dietary arginine utilization for NO compared with urea synthesis and studied the characteristics of the arginine-NO metabolic system in healthy humans. DESIGN We traced the metabolic fate and analyzed the utilization dynamics of dietary arginine after its ingestion at 2 nutritional amounts in healthy humans (n = 9) in a crossover design by using [(15)N-(15)N-(guanido)]-arginine, isotope ratio mass spectrometry techniques, and data analysis with a compartmental modeling approach. RESULTS Whatever the amount of dietary arginine, 60 ± 3% (±SEM) was converted to urea, with kinetics indicative of a first-pass splanchnic phenomenon. Despite this dramatic extraction, intact dietary arginine made a major contribution to the postprandial increase in plasma arginine. However, the model identified that the plasma compartment was a very minor (~2%) precursor for the conversion of dietary arginine into NO, which, in any case, was small (<0.1% of the dose). The whole-body and plasma kinetics of arginine metabolism were consistent with the suggested competitive metabolism by the arginase and NO synthase pathways. CONCLUSIONS The conversion of oral/dietary arginine into NO is not limited by the systemic availability of arginine but by a tight metabolic compartmentation at the systemic level. We propose an organization of the arginine metabolic system that explains the daily maintenance of NO homeostasis in healthy humans.

[1]  N. Deutz,et al.  Regulation of nitric oxide production in health and disease , 2010, Current opinion in clinical nutrition and metabolic care.

[2]  C. Gaudichon,et al.  Absorption kinetics are a key factor regulating postprandial protein metabolism in response to qualitative and quantitative variations in protein intake. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  J. Huneau,et al.  Whole-body basal nitric oxide production is impaired in postprandial endothelial dysfunction in healthy rats. , 2009, Nitric oxide : biology and chemistry.

[4]  S. Morris,et al.  Recent advances in arginine metabolism: roles and regulation of the arginases. , 2009, British journal of pharmacology.

[5]  J. Aschner,et al.  Quantitative RT-PCR comparison of the urea and nitric oxide cycle gene transcripts in adult human tissues. , 2009, Molecular genetics and metabolism.

[6]  D. Burrin,et al.  Comparative aspects of tissue glutamine and proline metabolism. , 2008, The Journal of nutrition.

[7]  A. Shoukas,et al.  Mitochondrial arginase II constrains endothelial NOS-3 activity. , 2007, American journal of physiology. Heart and circulatory physiology.

[8]  M. Vettore,et al.  Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic study. , 2007, American journal of physiology. Endocrinology and metabolism.

[9]  J. Huneau,et al.  Meal amino acids with varied levels of arginine do not affect postprandial vascular endothelial function in healthy young men. , 2007, The Journal of nutrition.

[10]  S. Morris.  Arginine metabolism: boundaries of our knowledge. , 2007, The Journal of nutrition.

[11]  R. Böger.  The pharmacodynamics of L-arginine. , 2007, The Journal of nutrition.

[12]  L. Cynober.  Pharmacokinetics of arginine and related amino acids. , 2007, The Journal of nutrition.

[13]  N. Deutz,et al.  Methods using stable isotopes to measure nitric oxide (NO) synthesis in the L-arginine/NO pathway in health and disease. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  L. Ignarro,et al.  Low-dose l-arginine administration increases microperfusion of hindlimb muscle without affecting blood pressure in rats , 2007, Proceedings of the National Academy of Sciences.

[15]  Maria Pia Saccomani,et al.  Conceptual, methodological and computational issues concerning the compartmental modeling of a complex biological system: Postprandial inter-organ metabolism of dietary nitrogen in humans. , 2006, Mathematical biosciences.

[16]  C. Napoli,et al.  Nitric oxide and atherosclerosis: an update. , 2006, Nitric oxide : biology and chemistry.

[17]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[18]  S. Bode-Böger.  Effect of L-arginine supplementation on NO production in man , 2006, European Journal of Clinical Pharmacology.

[19]  S. Moncada,et al.  The discovery of nitric oxide and its role in vascular biology , 2006, British journal of pharmacology.

[20]  Peter H. Brown,et al.  Oral L-arginine improves hemodynamic responses to stress and reduces plasma homocysteine in hypercholesterolemic men. , 2005, The Journal of nutrition.

[21]  J. Thiessen,et al.  l-Arginine Transport in the Human Coronary and Peripheral Circulation , 2004, Circulation.

[22]  A. Shoukas,et al.  Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels , 2003, Circulation.

[23]  R. Ferrante,et al.  Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Cobelli,et al.  L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. , 2003, Diabetes.

[25]  N. Deutz,et al.  Isotopic investigation of nitric oxide metabolism in disease , 2003, Current opinion in clinical nutrition and metabolic care.

[26]  D. Herrington,et al.  Vascular effects of dietary L-arginine supplementation. , 2002, Atherosclerosis.

[27]  D. Eichler,et al.  Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. , 2001, Nitric oxide : biology and chemistry.

[28]  R. Benamouzig,et al.  Postprandial modulation of dietary and whole-body nitrogen utilization by carbohydrates in humans. , 2000, The American journal of clinical nutrition.

[29]  T. Gotoh,et al.  Regulation of nitric oxide production by arginine metabolic enzymes. , 2000, Biochemical and biophysical research communications.

[30]  D. Tsikas,et al.  Endogenous nitric oxide synthase inhibitors are responsible for the L‐arginine paradox , 2000, FEBS letters.

[31]  J. Loscalzo.  What we know and don't know about L-arginine and NO. , 2000, Circulation.

[32]  T. Blaschke,et al.  Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. , 1999, British journal of clinical pharmacology.

[33]  Guoyao Wu,et al.  Arginine metabolism: nitric oxide and beyond. , 1998, The Biochemical journal.

[34]  Guoyao Wu,et al.  Intestinal mucosal amino acid catabolism. , 1998, The Journal of nutrition.

[35]  D. Harrison,et al.  Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.

[36]  D. Harrison,et al.  Insulin and the arginine paradox. , 1997, The Journal of clinical investigation.

[37]  V. Young,et al.  Whole body nitric oxide synthesis in healthy men determined from [15N] arginine-to-[15N]citrulline labeling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  V. Young,et al.  Urea cycle intermediate kinetics and nitrate excretion at normal and "therapeutic" intakes of arginine in humans. , 1995, The American journal of physiology.

[39]  S. Moncada,et al.  Molecular mechanisms and therapeutic strategies related to nitric oxide , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  C. Ryan,et al.  Plasma arginine and leucine kinetics and urea production rates in burn patients. , 1995, Metabolism: clinical and experimental.

[41]  P. Klein,et al.  Isotopic evidence for the differential regulation of arginine and proline synthesis in man. , 1995, Metabolism: clinical and experimental.

[42]  J. F. Burke,et al.  The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. F. Burke,et al.  Dietary arginine uptake by the splanchnic region in adult humans. , 1993, The American journal of physiology.

[44]  J. F. Burke,et al.  Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Stroebel,et al.  Erythrocyte volume, plasma volume, and lean body mass in adult men and women. , 1969, Blood.

[46]  R. Hui,et al.  Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials. , 2009, The American journal of clinical nutrition.

[47]  C. Dejong,et al.  Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. , 2007, The American journal of clinical nutrition.

[48]  Guoyao Wu,et al.  Regulation of nitric oxide synthesis by dietary factors. , 2002, Annual review of nutrition.

[49]  N. Benjamin,et al.  Measurement of nitric oxide synthesis in humans using L-[15N2]arginine. , 1999, Methods in enzymology.

[50]  S. Tannenbaum,et al.  Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. , 1993, Proceedings of the National Academy of Sciences of the United States of America.